AI assistant
H. Lundbeck A Major Shareholding Notification 2008
3367_mrq_2008-07-31_4ef2ddb1-9f9e-4a02-8d0a-314a1020c59e.html
Major Shareholding Notification
Open in viewerOpens in your device viewer
Announcement regarding principal shareholder's ownership of Lundbeck
Announcement regarding principal shareholder's ownership of Lundbeck
On 31 July 2008, H. Lundbeck A/S was notified that LFI A/S (the Lundbeck Foundation) after today's registered change of the H. Lundbeck A/S' share capital holds 69.7621% of the shares in Lundbeck corresponding to 137,351,918 shares.
Lundbeck contacts
| Investors: | Media: |
| Jacob Tolstrup | Mads Vindahl Kronborg |
| Director | Media Relations |
| +45 36 43 30 79 | +45 36 43 28 51 |
| Palle Holm Olesen | |
| Head of Investor Relations | |
| +45 36 43 24 26 |
Release No 351 - 31 July 2008
About Lundbeck
H. Lundbeck A/S is an international pharmaceutical company engaged in the research and development, production, marketing and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders. In 2007, the company's revenue was DKK 11 billion (approximately EUR 1.6 billion or USD 2.0 billion). The number of employees is approx. 5,300 globally. For more information, please visit www.lundbeck.com.
Attachments:
This content was distributed through
- connecting communication professionals with their target audience. Visit us here.